Can Adrenal Cancer Cause Numbness? Mechanisms and Clinical Considerations

Numbness (a loss or change in sensation) can be associated with adrenal cancer, but it is usually an indirect effect rather than a primary symptom of the tumor itself. The most common pathways include chemotherapy‑induced neuropathy, paraneoplastic neurological syndromes, hormonal imbalances (especially severe cortisol excess), metabolic complications like low potassium (hypokalemia), and less commonly nerve compression from local tumor growth or metastases. ^{[1] [2]}

---

Overview of Adrenal Cancer and Typical Symptoms

Adrenocortical carcinoma (ACC) is a rare cancer of the adrenal cortex; many tumors produce excess hormones that cause systemic symptoms such as Cushing’s syndrome, virilization, or, less commonly, hypertension with hypokalemia. ^[3] Most adrenal tumors are benign and often do not cause symptoms unless they secrete hormones or grow large enough to press on nearby structures. ^{[4] [5]}

---

How Numbness Can Arise

1) Chemotherapy‑Induced Peripheral Neuropathy

• Certain chemotherapy drugs used to treat malignant adrenal tumors can damage peripheral nerves, leading to numbness, tingling, burning pain, and weakness in the hands and feet. ^[1] These symptoms are recognized complications of cancer treatment and may persist after therapy, depending on the agent and cumulative dose. ^[6]

2) Paraneoplastic Neurological Syndromes (PNS)

• Some cancers trigger immune‑mediated attacks on the nervous system, known as paraneoplastic syndromes. ^[7] In the peripheral nervous system, a classic manifestation is subacute sensory neuronopathy, which can present with sensory ataxia and widespread numbness. ^[2] While less common in adrenal cancer than in some other tumors, paraneoplastic neuropathies are well‑documented cancer‑related phenomena and warrant evaluation when symptoms are disproportionate to local tumor effects. ^{[7] [2]}

3) Hormone Excess and Metabolic Complications

• ACC frequently causes excess cortisol (Cushing’s syndrome), which can lead to muscle weakness, glucose abnormalities, and susceptibility to infections; severe endocrine disturbances may indirectly contribute to neuropathy or exacerbate nerve symptoms. ^[8] Persistent hormonal excess is considered a serious, malignant manifestation requiring aggressive management. ^[3]
• Hypokalemia (low potassium) from mineralocorticoid effects can cause muscle cramps, weakness, and sometimes paresthesias that feel like numbness; correcting potassium and controlling hormone output often improves these symptoms. ^[3]

4) Local Mass Effect or Metastatic Disease

• Large adrenal tumors may press on adjacent tissues and, in advanced cases, metastatic spread can involve areas near major nerve pathways, potentially causing regional pain, weakness, or sensory changes. ^[9] Although adrenal tumors more commonly cause abdominal symptoms or fullness when large, nerve‑related symptoms from compression or metastasis are a plausible mechanism in select scenarios. ^[9]

---

Treatment Side Effects and Symptom Management

• When neuropathy is related to chemotherapy, clinicians may prescribe medications for nerve pain (for example, certain antidepressants or anticonvulsants) and recommend rehabilitation programs to maintain balance, strength, and daily function. ^[6] Adjusting chemotherapy regimens, dose reductions, or switching agents may be considered if neuropathy becomes dose‑limiting. ^[6]
• For hormone‑producing ACC, steroidogenesis inhibitors such as mitotane, ketoconazole, metyrapone, or etomidate are commonly used to reduce excess cortisol when surgery is not feasible or as adjuvant therapy, which can help stabilize systemic complications that might worsen neuropathic symptoms. ^[3] Close follow‑up and frequent dose adjustments are usually required due to the complexity of endocrine control in ACC. ^[8]

---

Red Flags That Warrant Urgent Evaluation

• Rapidly progressive numbness, new weakness, difficulty walking (sensory ataxia), or autonomic symptoms (blood pressure swings, bladder dysfunction) should prompt urgent neurological assessment to rule out PNS, spinal cord involvement, or severe metabolic derangements. ^[2] Sudden changes in symptoms during or after chemotherapy should also be reviewed promptly to prevent permanent nerve damage. ^{[1] [6]}

---

Practical Diagnostic Approach

• Clinical exam focused on sensory and motor deficits.
• Labs to assess electrolytes (especially potassium), glucose, and hormone levels (cortisol and androgens) to identify endocrine causes. ^{[3] [8]}
• Nerve conduction studies and electromyography if neuropathy is suspected; onconeuronal antibody testing (e.g., anti‑Hu, anti‑CV2/CRMP5) when PNS is considered. ^[2]
• Imaging to evaluate tumor size, local invasion, and possible metastases if structural compression is suspected. ^{[9] [8]}

---

Key Takeaways

• Yes, numbness can be associated with adrenal cancer, most often via chemotherapy‑induced neuropathy, paraneoplastic immune effects, hormone‑related metabolic issues like hypokalemia, or mass/metastatic compression. ^{[1] [2]}
• Controlling hormone excess and addressing treatment‑related neuropathy are central to symptom relief. ^{[3] [6]}
• Early recognition and multidisciplinary management (oncology, endocrinology, neurology, rehabilitation) improve outcomes and quality of life. ^{[8] [6]}

---

Summary Table: Mechanisms of Numbness in Adrenal Cancer

Mechanism	Typical Features	How It Causes Numbness	Clinical Actions
Chemotherapy‑induced neuropathy	Tingling, burning, stocking‑glove numbness, weakness	Direct toxic effect on peripheral nerves	Adjust chemo; neuropathic pain meds; rehab support [1] [6]
Paraneoplastic neuropathy (PNS)	Subacute sensory neuronopathy, sensory ataxia	Immune attack on sensory neurons (dorsal root ganglia)	Neurology work‑up; onconeuronal antibodies; treat underlying cancer [2] [7]
Hormone excess (cortisol)	Cushingoid features, glucose changes, weakness	Systemic endocrine/metabolic stress worsening nerve function	Steroidogenesis inhibitors; endocrine management [3] [8]
Hypokalemia from mineralocorticoids	Cramps, weakness, paresthesias	Low potassium affecting nerve/muscle excitability	Correct potassium; control hormone output [3]
Mass effect/metastases	Regional pain, focal deficits	Compression/infiltration of nerves or plexuses	Imaging; local control measures; oncologic management [9]

---

If you’re experiencing new or worsening numbness during adrenal cancer treatment, it may help to share details such as timing relative to chemotherapy, distribution of symptoms (hands/feet vs. one limb), and any signs of hormonal imbalance so your care team can pinpoint the most likely cause.